Resource Centre Back to Resource Centre Advanced filters Buy access Events7th European Multidisciplinary Meeting on Urological Cancers (116)Media TypePosters (116)Sessions
Filters Reset Events:7th European Multidisciplinary Meeting on Urological Cancers (116)Media Types:Posters (116)Sessions: 116 results (Loading...) Video Filters× organeaccessprocedurepathology116 PostersSHOW: 525 ITEMS PER PAGESORT BY: DATEDATETITLETITLE P082: Usefulness of predictive nomograms in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC) treated with ketoconazoleRomán Martín A.A., Parra Lopez L., Corchuelo-Maíllo C., Osman-García I., Congregado-Ruiz C.B., Conde-Sánchez J.M., Medina-López R.A.12 Nov 2015940Close Poster P095: Preferences for the management of androgen deprivation-induced osteoporosis and metabolic syndrome in prostate cancer patients: A European web-based surveyBultijnck R.2, Surcel C.3, Ploussard G.4, Briganti A.5, De Visschere P.6, Fütterer J.7, Ghadjar P.8, Giannarini G.9, Isbarn H.10, Massard C.11, Sooriakumaran P.12, Van Den Bergh R.13, Ost P.112 Nov 2015825Close Poster P103: Evans blue as a diagnostic tool for non-muscle-invasive bladder cancerElsen S.1, Lerut E.2, Van Cleynenbreugel B.3, Van Der Aa F.3, Van Poppel H.3, De Witte P.112 Nov 2015757Close Poster P012: Transparency of pathologic results after radical prostatectomy in the BeneluxFossion L.M.C.L., Vermeulen C.K.M.12 Nov 201514.269Close Poster P017: Profile of acute toxicity in prostate cancer with image guided radiotherapy and fiducial markersSalas C., De Ingunza Barón L., Gutiérrez Bayard L., Garduño Sánchez S.12 Nov 2015700Close Poster P023: Long term Toxicity and quality of life after high-dose-rate brachytherapy as monotherapy for low- and intermediate-risk prostate cancerAluwini S.1, Busser W.1, Boormans J.2, Kirkels W.2, Praag J.1, Jansen P.1, Kolkman-Deurloo I-K.1, Bangma C.212 Nov 2015379Close Poster P033: Quality of life of men on active surveillance for prostate cancer versus men without prostate cancer: Are there any differences?Venderbos L.D.F.1, Korfage I.J.2, Roobol M.J.112 Nov 2015741Close Poster P054: Survival after biochemical failure in prostate cancer: Recap database outcomesGonzález-San Segundo C.1, Jové J.2, Zapatero A.2, Pastor Peidro J.R.3, Muñoz-Garzón V.4, Casaña M.5, Mengual J.L.6, Gómez-Caamaño A.7, Vallejo Ocaña C.8, Henriquez I.9, Muñoz J.10, Clemente J.6, Porras M.11, Ossola Lentati G.12, Collado Ballesteros E.13, Villafranca Iturre E.14, Cabeza Rodríguez A.1512 Nov 2015391Close Poster P063: Long term clinical outcomes and toxicity of salvage radiotherapy after radical prostatectomy for prostate cancer patientsAluwini S.1, Van Dessel L.2, Sarah R.1, Bangma C.1, Jansen P. P.312 Nov 2015330Close Poster P071: Testosterone suppression with an innovative form of leuprorelin acetate as solid biodegradable implant in patients with advanced prostate cancer. Results from four trials and comparison with traditional leuprorelin acetate microcapsules formulationSolarić M.2, Bjartell A.3, Thyroff-Friesinger U.4, Meani D.112 Nov 2015356Close Poster P073: Phase 1b study of ARN-509 with abiraterone acetate and prednisone in patients with metastatic Castration-Resistant Prostate Cancer (mCRPC)Posadas E.1, Chi K.N.2, De Wit R.3, De Jonge M.J.A.3, Attard G.4, Friedlander T.5, Yu M.K.6, Hellemans P.7, Chien C.8, Abrams C.9, Gonzalez M.10, Trudel G.C.6, Chauhan V.11, Jiao J.11, Saad F.1212 Nov 2015322Close Poster EP168: Evaluation of chemotherapy response in seminomasCosta A.L.1, Abreu C.1, Pacheco T.1, Ortega A.2, Mulet N.2, Jimenez L.2, Piulats J.M.2, Quintela A.1, Costa L.1, Garcia Del Muro X.212 Nov 2015336Close Poster EP168: 12 Nov 2015329Close Poster EP177: Tumour size in MRI and percentage of cancer in biopsy are independent predictors of side-specific pathologic T3 prostate cancerDybowski B.1, Bres-Niewada E.1, Lorenc T.2, Powała A.3, Borkowski T.1, Radziszewski P.112 Nov 2015402Close Poster P143: Treatment of renal cell carcinoma of native kidney in kidney transplantationLedo Cepero M.J., Parra Servan P., Ojeda A.V., León Delgado C., Rosety Rodriguez J., Amores Bermúdez J., Cañete Bermúdez J., Pérez-Lanzac A., Alvarez-Ossorio Fernández J.L12 Nov 2015253Close Poster P150: Radical nephrectomy vs partial nephrectomy in patients with localized renal cell carcinoma and normal contralateral kidneyVolkova M.I.1, Skvortcov I.Ya.2, Chernyaev V.A.1, Klimov A.V.1, Kalinin S.A.1, Peters M.V.2, Matveev V.B.112 Nov 2015303Close Poster P152: Prognostic factors of perioperative outcomes of RCC patients with IVC thrombosisMatveev V.1, Volkova M.I.1, Feoktistov P.I.2, Zguzgginova O.V.3, Nekhaev I.V.3, Lomidze S.V.3, Klimov A.V.1, Kalinin S.A.112 Nov 2015346Close Poster P158: Do real-world outpatient patients resemble the population selected in a clinical trial?Abreu C., Costa A.L., Pacheco T., Quintela A., Costa L.12 Nov 2015311Close Poster P109: Variations in pelvic lymph node dissection in clinical stage I-III bladder cancer: A Dutch nationwide population-based studyHermans T.J.N.1, Fossion L.M.C.L.2, Van Rhijn B.W.G.1, Fransen Van De Putte E.E.1, Verhoeven R.H.A.3, Horenblas S.112 Nov 2015340Close Poster P046: A Phase 3 study of enzalutamide in non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) patientsHeidenreich A.1, Sternberg C.N.2, Fizazi K.3, Saad F.4, Shore N.5, Hirmand M.6, Van Os S.7, Akella L.8, Modelska K.9, Hussain M.1012 Nov 2015388Close Poster P117: Prescribing platinum chemotherapy based on glomerular filtration rate using wright formula instead of nuclear medicine radioactive technetium-99m for transitional cell carcinoma of bladderSundaramurthy A., Malik J.M., Mclaren D.B., Law A.B.12 Nov 2015335Close Poster P125: Clinical significance of Topoisomerase II, Ki-67 and P53 expression in non-muscle invasive urothelial carcinomaElkhouly E.A.1, Elkady N.2, Sultan M.312 Nov 2015323Close Poster P131: Patterns of failure and predictors of recurrence for urothelial bladder cancer after radical cystectomyAli A.M., Abulkassem H., Shawky A.12 Nov 2015339Close Poster P163: Does bilateral testicular germ cell tumours have worse prognostic features? Single tertiary referral center experienceAkdoğan B., Citamak B., Altan M., Özen H.12 Nov 2015267Close Poster EP169: MpMRI-Histopathologic correlation of normal, benign and malignant conditions of the prostateDe Visschere P.1, Vral A.2, Perletti G.3, Pattyn E.1, Villeirs G.112 Nov 2015301Close Poster «12345» ×